Sign In / Register
Make This My Home Page | Feedback |RSS
You are here: IE »   Story

The source of Depression

  • Print
  • Mail This Article
  • Comments
  • Add to favorites
  • Ketamine, answer to our glutamatergic dreams. In the long November night of the soul, in the ever-dark downpour of depression, it turns out that there might be a better umbrella than Prozac and Zoloft and Paxil and their serotonin-loving ilk.

    When it comes to antidepressants, nobody really knows anything, anyway, so why not go with ketamine, a mild hallucinogen known to club freaks as Special K?

    Researchers at the National Institute of Mental Health announced a study recently in which 18 chronically depressed patients infused with low dosages of ketamine improved within two hours. Seventy-one percent improved within a day, and nearly 30 percent were depression-free by that time. These were people who had been dealing with depression from three to 47 years. They had failed to respond to just about every drug. Most of them stayed depression-free for up to a week.

    Ads by Google

    Doesn’t it make Prozac and friends look like punks? The subsequent news stories focused on the speed—antidepressants generally take two weeks or longer to work—but the true breakthrough, scientists say, is that ketamine seems to do something entirely new. It focuses on glutamate, a chemical neurotransmitter that is involved in electrical flow among brain cells, which previously had not been targeted.

    Think of depression as a leaky water faucet in the kitchen of the mind. Prozac and friends start working on the problem back at the water plant and, in about half of the cases, eventually find the problem. In this trial, glutamate (and the “glutamatergic system’’) was shown to be a wrench-toting plumber who makes house calls. It got right to the problem. “It’s not quite the director of the orchestra, but it’s involved with many other systems in the brain than other antidepressants,’’ said Carlos Zarate, chief of the mood disorders research unit at NIMH, and lead author of the study.

    ... contd.

    Next12
    Comments
    Post comment

    Be the first to comment.

    Post a Comment
    Name:
    Email:
    Title:
    Maximum characters allowed     
    Comment:
    TERMS OF USE:
    The views, opinions and comments posted are your, and are not endorsed by this website. You shall be solely responsible for the comment posted here. The website reserves the right to delete, reject, or otherwise remove any views, opinions and comments posted or part thereof. You shall ensure that the comment is not inflammatory, abusive, derogatory, defamatory &/or obscene, or contain pornographic matter and/or does not constitute hate mail, or violate privacy of any person (s) or breach confidentiality or otherwise is illegal, immoral or contrary to public policy. Nor should it contain anything infringing copyright &/or intellectual property rights of any person(s).
    I agree to the terms of use.